160 related articles for article (PubMed ID: 19480939)
1. Isolated deletion of 6q in a patient with myelodysplastic syndrome.
Gozzetti A; Crupi R; Defina M; Bocchia M; Raspadori D; Lauria F
Cancer Genet Cytogenet; 2009 Jul; 192(1):51. PubMed ID: 19480939
[No Abstract] [Full Text] [Related]
2. Isolated interstitial 9q deletion in a case of unclassifiable myelodysplastic syndrome.
Feitosa Pinheiro R; Maranhão Bahia D; Artur Flores Pelloso L; Guimaraes Vaz De Campos M; De Lourdes Chauffaille M
Cancer Genet Cytogenet; 2004 Sep; 153(2):183-4. PubMed ID: 15350312
[No Abstract] [Full Text] [Related]
3. [Myelodysplastic syndrome associated with 5q deletion, review of 3 cases].
Khanfir A; Frikha M; Mseddi S; Elloumi M; Daoud J; Makni F; Amouri A; Gargouri J; Saad A; Souissi T
Tunis Med; 1997 Mar; 75(3):127-31. PubMed ID: 9506035
[No Abstract] [Full Text] [Related]
4. Myelodysplastic syndrome with isolated 5q deletion (5q- syndrome). A clonal stem cell disorder characterized by defective ribosome biogenesis.
Cazzola M
Haematologica; 2008 Jul; 93(7):967-72. PubMed ID: 18591621
[No Abstract] [Full Text] [Related]
5. [Apropos of the case "Erythroblastopenia associated with myelodysplastic syndrome"].
Aventín A
Sangre (Barc); 1996 Dec; 41(6):483. PubMed ID: 9148428
[No Abstract] [Full Text] [Related]
6. Acquired erythropoietic protoporphyria as a result of myelodysplasia causing loss of chromosome 18.
Sarkany RP; Ross G; Willis F
Br J Dermatol; 2006 Aug; 155(2):464-6. PubMed ID: 16882191
[TBL] [Abstract][Full Text] [Related]
7. Translocation (10;21)(q21;q22) in myelodysplastic syndrome.
Rashaan Z; Ito Y; Takaku T; Toyotake J; Miyazawa K; Kodama A; Ohyashiki K
Cancer Genet Cytogenet; 2007 Feb; 173(1):81-2. PubMed ID: 17284376
[No Abstract] [Full Text] [Related]
8. Isochromosome of a deleted 20q may be a relatively common abnormality in myeloid malignancies.
Ligon AH; DeAngelo DJ; Atkins L; Dal Cin P
Cancer Genet Cytogenet; 2005 Oct; 162(1):89-91. PubMed ID: 16157208
[No Abstract] [Full Text] [Related]
9. Prognostic significance of deletion of the long arm of chromosome 20 in patients with myelodysplastic syndrome (MDS): a study of the Greek MDS Study Group.
Galanopoulos AG; Symeonidis A; Kourakli A; Papadaki EA; Tsaftaridis P; Terpos E; Aktipi A; Roussou P; Protopappa M; Pappaioannou M; Zikos P; Speletas M; Parcharidou A; Laoutaris N; Anagnostopoulos NI; Meletis J; Pangalis GA; Zoumbos N; Viniou N;
Eur J Haematol; 2007 Jan; 78(1):89-90. PubMed ID: 17302860
[No Abstract] [Full Text] [Related]
10. Myelodysplastic syndromes.
Tefferi A; Vardiman JW
N Engl J Med; 2009 Nov; 361(19):1872-85. PubMed ID: 19890130
[No Abstract] [Full Text] [Related]
11. Terminal deletion of 6q and Fryns syndrome: a microdeletion/syndrome pair?
Krassikoff N; Sekhon GS
Am J Med Genet; 1990 Jul; 36(3):363-4. PubMed ID: 2363440
[No Abstract] [Full Text] [Related]
12. [A particular myelodysplasia: 17p- syndrome].
Fourcade C; Jary L; Mossafa H; Louvel D
Ann Biol Clin (Paris); 1998; 56(6):724-6. PubMed ID: 9853033
[No Abstract] [Full Text] [Related]
13. Revealing the pathogenesis of the 5q- syndrome.
Valent P
Eur J Clin Invest; 2008 Aug; 38(8):539-40. PubMed ID: 18717823
[No Abstract] [Full Text] [Related]
14. A novel t(11;14)(q23;q32) in a case of myelodysplastic syndrome.
Yujiri T; Miyazaki M; Imoto S
Cancer Genet Cytogenet; 2009 Jan; 188(2):124-5. PubMed ID: 19100518
[No Abstract] [Full Text] [Related]
15. The 5q- syndrome.
Giagounidis AA; Aul C
Cancer Treat Res; 2008; 142():133-48. PubMed ID: 18283785
[No Abstract] [Full Text] [Related]
16. Cryptic deletion of EGR1 in association with a novel balanced t(5;22)(q31;q11.2) in a patient with myelodysplastic syndrome.
Hoffman MW; Janney S; Batanian JR
Cancer Genet Cytogenet; 2009 Jun; 191(2):106-8. PubMed ID: 19446747
[TBL] [Abstract][Full Text] [Related]
17. Loss of the extra chromosome 21 in a patient with Down syndrome and myelodysplasia.
Tan D; Lau LC; Teng LM; Sane S; Lim TH; Tien SL
Cancer Genet Cytogenet; 2008 Jan; 180(1):79-82. PubMed ID: 18068540
[TBL] [Abstract][Full Text] [Related]
18. Therapy-related myelodysplastic syndrome with 17p deletion following long-term azathioprine treatment.
Heredia F; Sousa J; Magalhães S; Pinheiro R
Leuk Res; 2010 Nov; 34(11):e311-2. PubMed ID: 20674015
[No Abstract] [Full Text] [Related]
19. Deletion 9q in a patient with concomitant myelodysplasia and non-Hodgkin lymphoma.
Gozzetti A; Calabrese S; Crupi R; Tozzuoli D; Fabbri A; Bocchia M; Pirrotta MT; Defina M; Lauria F
Cancer Genet Cytogenet; 2007 Jun; 175(2):177. PubMed ID: 17556078
[No Abstract] [Full Text] [Related]
20. A delayed yet durable response to very short lenalidomide therapy and unexpected clone redistribution in a case of myelodysplastic syndrome with del(5q) and del(20q).
Xu F; Li X; Chang C; He Q; Zhang Z; Zhang Q; Wu L
Leuk Res; 2009 Nov; 33(11):e199-202. PubMed ID: 19592091
[No Abstract] [Full Text] [Related]
[Next] [New Search]
